One possible outcome is that Quintana appoints an administrator and both shareholders and noteholders get nothing. If Quintana is backing the existing board then you are wasting your time. Just my thoughts, DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%